Molecular Imaging: Page 69

AC Immune receives grant to support a-syn PET tracer development

By AuntMinnie.com staff writers

Swiss biopharmaceutical company AC Immune has received a $500,000 grant from the Michael J. Fox Foundation for Parkinson's Research (MJFF) to continue development of its alpha-synuclein (a-syn) PET tracer, ACI-12589.

September 5, 2022

First patient in Oncoinvent trial treated for colorectal cancer

By AuntMinnie.com staff writers

Norwegian radiopharmaceutical developer Oncoinvent is highlighting that the first colorectal cancer patient has been treated in a clinical trial of the company's Radspherin drug candidate.

August 25, 2022

Anthropomorphic phantoms from Sun Nuclear bound for space

By AuntMinnie.com staff writers

A pair of Sun Nuclear anthropomorphic phantoms will travel aboard NASA's Orion spacecraft as part of an upcoming mission aimed at enabling human exploration to the moon and Mars.

August 24, 2022

New PET tracer effective for diagnosing neuroendocrine tumors

By Will Morton

A new gallium-68 PET radiotracer appears effective for predicting higher risk of disease progression and mortality in patients with neuroendocrine tumors, according to a study published August 18 in the Journal of Nuclear Medicine.

August 24, 2022

AuntMinnie.com Molecular Imaging Insider

By Will Morton

August 23, 2022

AtomVie raises $40M to build new radiopharmaceutical facility

By AuntMinnie.com staff writers

AtomVie Global Radiopharma has received at least $40 million in financing that will be used to build a new facility to expand its radiopharmaceutical manufacturing.

August 23, 2022

Combining imaging with liquid biopsy for cervical cancer

By AuntMinnie.com staff writers

The role of imaging has been increasing in cervical cancer for pretherapy planning and response assessment, but there’s room for improvement, according to a review article published on Tuesday in the Journal of Computer Assisted Tomography (JCAT).

August 22, 2022

NorthStar inks supply deal with Aktis Oncology

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has inked a long-term supply agreement with Aktis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.

August 22, 2022

Do PET/CT reports contain riddles for oncologists?

By Will Morton

Key information on PET/CT imaging reports on whether head and neck cancer patients are responding to radiotherapy may not be getting through to clinicians, according to research published August 18 in JAMA Otolaryngology -- Head & Neck Surgery.

August 22, 2022

United Imaging goes public on Shanghai stock exchange

By AuntMinnie.com staff writers

United Imaging Healthcare on August 22 launched an initial public offering on the Science and Technology Innovation Board of the Shanghai Stock Exchange.

August 21, 2022

PET reveals best timing for trials of Alzheimer's disease drugs

By Will Morton

PET scans can detect early signs of Alzheimer's disease long before other biomarkers, a study published August 22 in JAMA Neurology has found. The discovery could mean research studies for drugs to treat Alzheimer's should start at an earlier stage.

August 21, 2022

Shine names D'Orazio CEO of Phoenix

By AuntMinnie.com staff writers

Shine Technologies recently named Tom D'Orazio as the CEO of its industrial imaging arm, Phoenix. Both companies are wholly owned subsidiaries of Illuminated Holdings.

August 18, 2022

Previous Page

Page 69 of 620

Next Page